375 related articles for article (PubMed ID: 20621999)
1. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.
Waldmann J; Fendrich V; Holler J; Buchholz M; Heinmöller E; Langer P; Ramaswamy A; Samans B; Walz MK; Rothmund M; Bartsch DK; Slater EP
Endocr Relat Cancer; 2010 Sep; 17(3):743-56. PubMed ID: 20562231
[TBL] [Abstract][Full Text] [Related]
3. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
[TBL] [Abstract][Full Text] [Related]
5. Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival.
Thouënnon E; Pierre A; Tanguy Y; Guillemot J; Manecka DL; Guérin M; Ouafik L; Muresan M; Klein M; Bertherat J; Lefebvre H; Plouin PF; Yon L; Anouar Y
Endocr Relat Cancer; 2010 Sep; 17(3):637-51. PubMed ID: 20483910
[TBL] [Abstract][Full Text] [Related]
6. Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.
Belian E; Kurucz R; Treue D; Lage H
Anticancer Res; 2010 Feb; 30(2):629-33. PubMed ID: 20332481
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
8. Stathmin as a marker for malignancy in pheochromocytomas.
Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
[TBL] [Abstract][Full Text] [Related]
11. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
12. Differentially expressed microRNAs in small cell lung cancer.
Miko E; Czimmerer Z; Csánky E; Boros G; Buslig J; Dezso B; Scholtz B
Exp Lung Res; 2009 Oct; 35(8):646-64. PubMed ID: 19895320
[TBL] [Abstract][Full Text] [Related]
13. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
14. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
[TBL] [Abstract][Full Text] [Related]
15. Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.
Xu X; Jia R; Zhou Y; Song X; Wang J; Qian G; Ge S; Fan X
Int J Oncol; 2011 May; 38(5):1385-93. PubMed ID: 21373755
[TBL] [Abstract][Full Text] [Related]
16. The role of microRNA in human lung squamous cell carcinoma.
Yang Y; Li X; Yang Q; Wang X; Zhou Y; Jiang T; Ma Q; Wang YJ
Cancer Genet Cytogenet; 2010 Jul; 200(2):127-33. PubMed ID: 20620595
[TBL] [Abstract][Full Text] [Related]
17. Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells.
Hohjoh H; Fukushima T
Biochem Biophys Res Commun; 2007 Oct; 362(2):360-7. PubMed ID: 17716626
[TBL] [Abstract][Full Text] [Related]
18. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.
Patterson E; Webb R; Weisbrod A; Bian B; He M; Zhang L; Holloway AK; Krishna R; Nilubol N; Pacak K; Kebebew E
Endocr Relat Cancer; 2012 Apr; 19(2):157-66. PubMed ID: 22241719
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas.
Liu W; Gong YH; Chao TF; Peng XZ; Yuan JG; Ma ZY; Jia G; Zhao JZ
Chin Med J (Engl); 2009 Oct; 122(20):2405-11. PubMed ID: 20079150
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
